Novel cardiovascular risk markers: early outcomes and determinants in the National Survey of Health and Development

新的心血管风险标记:国家健康与发展调查中的早期结果和决定因素

基本信息

  • 批准号:
    G1001143/1
  • 负责人:
  • 金额:
    $ 51.71万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2011
  • 资助国家:
    英国
  • 起止时间:
    2011 至 无数据
  • 项目状态:
    已结题

项目摘要

Diseases of the heart and circulation (together referred to as cardiovascular disease) remain important causes of ill-health and death both in middle-age and in later life. Prevention of these conditions remains an important public health priority. Although several risk factors are well known, novel biological pathways have also been implicated in the development of cardiovascular disease risk. These pathways involve the heart muscle and blood vessel linings, inflammatory processes, fat cells, the function of the kidneys, liver, and pancreas, circulating lipids and nutritional factors (particularly vitamin D). The role of these factors needs to be studied further. The unique 1946 British Birth Cohort (a study of more than 2000 individuals followed in detail from birth to 60-64 years) provides an important opportunity to provide novel insights into the role of these factors. Using this study framework it will be possible to examine the influence of these novel pathway markers on the structure and function of the heart and arteries in middle-age. The investigation will also provide an important opportunity to identify the factors which have the biggest influence on these novel pathway markers. These influences may well operate at different stages of life between conception and middle age, reflecting the fact that at least some of the factors responsible for cardiovascular disease risk operate before adult life. The study will help to determine whether these novel biological pathways mediate the effects of factors operating on cardiovascular disease at different stages during life (for example nutrition in early life) and the effects of socioeconomic factors, which are strongly related to cardiovascular risk. The information provided by the study will improve our understanding of how cardiovascular risk develops through life, and will help to tell us how best to prevent cardiovascular disease at different stages of the life course.
心脏和循环系统疾病(统称为心血管疾病)仍然是中年和晚年健康不良和死亡的重要原因。预防这些疾病仍然是重要的公共卫生优先事项。虽然有几个风险因素是众所周知的,但新的生物学途径也与心血管疾病风险的发展有关。这些途径涉及心肌和血管衬里,炎症过程,脂肪细胞,肾脏,肝脏和胰腺的功能,循环脂质和营养因子(特别是维生素D)。这些因素的作用需要进一步研究。独特的1946年英国出生队列(一项对2000多名从出生到60-64岁的人进行详细跟踪的研究)提供了一个重要的机会,为这些因素的作用提供了新的见解。使用这个研究框架,将有可能检查这些新的通路标记物对中年心脏和动脉的结构和功能的影响。这项研究还将提供一个重要的机会,以确定对这些新的途径标记物影响最大的因素。这些影响很可能在怀孕和中年之间的不同生命阶段起作用,反映了至少有一些导致心血管疾病风险的因素在成年之前起作用的事实。这项研究将有助于确定这些新的生物学途径是否介导了生命中不同阶段对心血管疾病起作用的因素的影响(例如生命早期的营养)以及与心血管风险密切相关的社会经济因素的影响。该研究提供的信息将提高我们对心血管风险如何在生命中发展的理解,并将有助于告诉我们如何在生命过程的不同阶段最好地预防心血管疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter Whincup其他文献

Associations between indicators of cardiovascular disease and pulse wave analysis and velocity: A comparison of devices
  • DOI:
    10.1016/j.artres.2018.10.019
  • 发表时间:
    2018-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Elizabeth Ellins;Lucy Lennon;Olia Papacosta;Goya Wannamethee;Peter Whincup;Julian Halcox
  • 通讯作者:
    Julian Halcox
Elevated adiponectin and increased risk of cardiovascular disease and mortality in asymptomatic older men: Does NT-proBNP explain the paradox?
  • DOI:
    10.1016/j.atherosclerosis.2010.07.037
  • 发表时间:
    2010-11-01
  • 期刊:
  • 影响因子:
  • 作者:
    Paul Welsh;Peter Whincup;Naveed Sattar;Goya Wannamethee
  • 通讯作者:
    Goya Wannamethee
Comparison of pulse wave analysis assessment methodology in elderly men
  • DOI:
    10.1016/j.artres.2017.10.108
  • 发表时间:
    2017-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Elizabeth Ellins;Kirsten Smith;Lucy Lennon;Olia Papacosta;Goya Wannamethee;Peter Whincup;Julian Halcox
  • 通讯作者:
    Julian Halcox

Peter Whincup的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter Whincup', 18)}}的其他基金

Early emergence of ethnic differences in chronic disease risk: the contribution of diet and physical activity
慢性病风险中种族差异的早期出现:饮食和身体活动的贡献
  • 批准号:
    G0501295/1
  • 财政年份:
    2006
  • 资助金额:
    $ 51.71万
  • 项目类别:
    Research Grant

相似国自然基金

组织蛋白酶CTSK在酒精性心肌病中对自噬溶酶体途径调控机制的研究
  • 批准号:
    31900534
  • 批准年份:
    2019
  • 资助金额:
    26.0 万元
  • 项目类别:
    青年科学基金项目
高尿酸血症促进动脉粥样硬化机制探讨
  • 批准号:
    81170251
  • 批准年份:
    2011
  • 资助金额:
    14.0 万元
  • 项目类别:
    面上项目

相似海外基金

Novel Computational Methods for Microbiome Data Analysis in Longitudinal Study
纵向研究中微生物组数据分析的新计算方法
  • 批准号:
    10660234
  • 财政年份:
    2023
  • 资助金额:
    $ 51.71万
  • 项目类别:
Novel Epigenetic Test for the Treatment and Improvement of Longitudinal Health-Outcomes for Men with Severe Infertility
用于治疗和改善严重不育男性纵向健康结果的新型表观遗传学测试
  • 批准号:
    10760354
  • 财政年份:
    2023
  • 资助金额:
    $ 51.71万
  • 项目类别:
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
  • 批准号:
    10733720
  • 财政年份:
    2023
  • 资助金额:
    $ 51.71万
  • 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
  • 批准号:
    10589484
  • 财政年份:
    2023
  • 资助金额:
    $ 51.71万
  • 项目类别:
Novel patient biomarkers and mechanisms of TKI associated Cardiotoxicity
TKI 相关心脏毒性的新型患者生物标志物和机制
  • 批准号:
    10728954
  • 财政年份:
    2023
  • 资助金额:
    $ 51.71万
  • 项目类别:
Novel Venous Device for the Treatment of Chronic Pelvic Pain
用于治疗慢性盆腔疼痛的新型静脉装置
  • 批准号:
    10696574
  • 财政年份:
    2023
  • 资助金额:
    $ 51.71万
  • 项目类别:
GMP Manufacturing and IND Enabling Studies of Extended-Release PNA5: A Novel Therapeutic for Treating Cognitive Impairment in Patients at-risk for Alzheimer's Disease-Related Dementias and Vascular
缓释 PNA5 的 GMP 生产和 IND 启用研究:一种治疗阿尔茨海默氏病相关痴呆和血管性认知障碍患者认知障碍的新疗法
  • 批准号:
    10819329
  • 财政年份:
    2023
  • 资助金额:
    $ 51.71万
  • 项目类别:
Cafe Move: A Novel Program for Prevention of Age-Related Physical Frailty
Cafe Move:预防与年龄相关的身体虚弱的新计划
  • 批准号:
    10861960
  • 财政年份:
    2023
  • 资助金额:
    $ 51.71万
  • 项目类别:
Understanding and Reducing Racial Bias in Cardiovascular Risk Prediction Using Novel AI Methods
使用新型人工智能方法理解和减少心血管风险预测中的种族偏见
  • 批准号:
    MR/Y000803/1
  • 财政年份:
    2023
  • 资助金额:
    $ 51.71万
  • 项目类别:
    Fellowship
A novel remote intervention to decelerate the age-related decline and disease development among older breast cancer survivors
一种新型远程干预措施,可减缓老年乳腺癌幸存者与年龄相关的衰退和疾病发展
  • 批准号:
    478415
  • 财政年份:
    2023
  • 资助金额:
    $ 51.71万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了